Determining the MTD involves a series of preclinical studies and clinical trials. Initially, the substance is tested in animal models to evaluate its toxicity and potential side effects. Researchers incrementally increase the dose until they identify the level at which adverse effects occur. This dose is then adjusted to determine the maximum level that can be tolerated without significant harm. Once animal trials are completed, the process moves to human trials, where the MTD is further refined.
